A Multiple Dose Pharmacokinetic Open-label Study Of Pregabalin (Lyrica Registered) In Healthy Lactating Women
Latest Information Update: 03 Feb 2021
At a glance
- Drugs Pregabalin (Primary)
- Indications Epilepsy; Fibromyalgia; Generalised anxiety disorder; Neuropathic pain; Partial epilepsies; Postherpetic neuralgia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jul 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 25 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.